-
Je něco špatně v tomto záznamu ?
Epicardial left ventricular lead for cardiac resynchronization therapy
M. Fedorco, A. Bulava, P. Šantavý, M. Táborský,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- implantované elektrody * MeSH
- lidé MeSH
- perikard chirurgie MeSH
- srdeční komory chirurgie MeSH
- srdeční resynchronizační terapie metody MeSH
- srdeční selhání chirurgie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Cardiac resynchronization therapy is now recognized as an effective and safe therapeutic modality in heart failure patients and leads to a reduction in mortality and morbidity. Today, transvenous implantation is considered to be the gold standard for lead placement. However, transvenous LV lead implantation fails in 2-10% of patients undergoing the implantation procedure. In these cases surgical LV lead implantation is preferred. The present article reviews LV pacing lead implantation strategies in cases where standard transvenous implantation failed.
České Budějovice Hospital Department of Cardiology Czech Republic
University Hospital Olomouc Department of Cardiology Czech Republic
University Hospital Olomouc Department of Cardiosurgery Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15013992
- 003
- CZ-PrNML
- 005
- 20170220083356.0
- 007
- ta
- 008
- 150420s2014 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)25433352
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Fedorco, Marián $u University Hospital Olomouc, Department of Cardiology, Czech Republic.
- 245 10
- $a Epicardial left ventricular lead for cardiac resynchronization therapy / $c M. Fedorco, A. Bulava, P. Šantavý, M. Táborský,
- 520 9_
- $a Cardiac resynchronization therapy is now recognized as an effective and safe therapeutic modality in heart failure patients and leads to a reduction in mortality and morbidity. Today, transvenous implantation is considered to be the gold standard for lead placement. However, transvenous LV lead implantation fails in 2-10% of patients undergoing the implantation procedure. In these cases surgical LV lead implantation is preferred. The present article reviews LV pacing lead implantation strategies in cases where standard transvenous implantation failed.
- 650 _2
- $a srdeční resynchronizační terapie $x metody $7 D058406
- 650 12
- $a implantované elektrody $7 D004567
- 650 _2
- $a srdeční selhání $x chirurgie $7 D006333
- 650 _2
- $a srdeční komory $x chirurgie $7 D006352
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a perikard $x chirurgie $7 D010496
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bulava, Alan $u České Budějovice Hospital, Department of Cardiology, Czech Republic.
- 700 1_
- $a Šantavý, Petr, $u University Hospital Olomouc, Department of Cardiosurgery, Czech Republic. $d 1973- $7 xx0211055
- 700 1_
- $a Táborský, Miloš $u University Hospital Olomouc, Department of Cardiology, Czech Republic.
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 35 Suppl 1, č. - (2014), s. 34-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25433352 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20170220083547 $b ABA008
- 999 __
- $a ok $b bmc $g 1071573 $s 896870
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 35 Suppl 1 $c - $d 34-9 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20150420
